carbapenems has been researched along with Renal Insufficiency in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Yu, Z; Zhao, Y | 1 |
| Bassetti, M; Carnelutti, A; Peghin, M; Righi, E | 1 |
| Chusri, S; Doi, Y; Kositpantawong, N; Panthuwong, S; Singkhamanan, K; Suphasynth, Y; Wanitsuwan, W | 1 |
| Changawala, N; Chapnick, E; Crusio, R; Kupfer, Y; Paul, V; Rao, S; Tiu, C; van Ginkel, J | 1 |
| Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A | 1 |
| Ishibashi, T; Kubota, R; Matsuo, Y; Wajima, T | 1 |
| Acikgoz, ZC; Guner, R; Guven, T; Izdes, S; Kocak Tufan, Z; Tasyaran, MA; Yilmaz, GR | 1 |
| Goto, K; Hagiwara, S; Hidaka, S; Iwasaka, H; Noguchi, T | 1 |
| Lin, R; Nandy, P; Samtani, MN | 1 |
| Bogard, KN; Erwin, MW; Fuller, PD; Olsen, KM; Peterson, NT; Plumb, TJ | 1 |
| Ben-Dov, IZ; Benenson, S; Bleumin, D; Bloch, A; Cohen, MJ; Esnault, VL; Haviv, YS; Levi, R; Mor-Yosef Levi, I; Moranne, O; Paltiel, O; Tzukert, K | 1 |
| Chang, J; Chung, KS; Jung, JY; Kang, YA; Kim, EY; Kim, SK; Kim, SY; Kim, YS; Lee, SK; Lim, JE; Park, BH; Park, MS; Park, SC | 1 |
| Aksungar, FB; Ozakkaş, F; Topkaya, AE; Tülbek, Y | 1 |
| Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
| Davies, BE; Kirkpatrick, C; Lennon, S; Liu, M; Luedin, E; Mallalieu, NL; Robson, R | 1 |
| Horrevorts, AM; Mouton, JW; Touzw, DJ; Vinks, AA | 1 |
3 review(s) available for carbapenems and Renal Insufficiency
| Article | Year |
|---|---|
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nebulizers and Vaporizers; Pneumonia; Pneumonia, Ventilator-Associated; Renal Insufficiency; Risk Factors | 2017 |
Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Critical Care; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Renal Insufficiency; Vancomycin | 2011 |
Comparative pharmacokinetics of the carbapenems: clinical implications.
Topics: Carbapenems; Drug Interactions; Humans; Renal Insufficiency; Structure-Activity Relationship | 2000 |
3 trial(s) available for carbapenems and Renal Insufficiency
| Article | Year |
|---|---|
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult | 2010 |
Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Intensive Care Units; Male; Middle Aged; Odds Ratio; Renal Insufficiency; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 2012 |
Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Creatinine; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Renal Insufficiency | 2008 |
10 other study(ies) available for carbapenems and Renal Insufficiency
| Article | Year |
|---|---|
Trough concentration may not be a good target for polymyxin B therapeutic drug monitoring.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Monitoring; Gram-Negative Bacteria; Humans; Polymyxin B; Renal Insufficiency | 2023 |
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Carbapenems; Colistin; Drug Resistance, Microbial; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Tigecycline | 2019 |
Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Polymyxin B; Prospective Studies; Renal Insufficiency; Rifampin; Survival Analysis; Treatment Outcome | 2014 |
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2013 |
Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Computer Simulation; Doripenem; Humans; Japan; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method; Renal Insufficiency; Young Adult | 2015 |
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Renal Insufficiency; Retrospective Studies; Sulbactam; Treatment Outcome | 2015 |
Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).
Topics: Aged; Aged, 80 and over; Carbapenems; Critical Illness; Doripenem; Female; Half-Life; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Renal Insufficiency | 2010 |
Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Female; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency; Risk Factors; Survival Analysis; Treatment Outcome | 2012 |
[A case of urinary tract infection caused by Flavimonas oryzihabitans].
Topics: Anti-Infective Agents, Urinary; Bacteriuria; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Pseudomonas; Pseudomonas Infections; Rectal Neoplasms; Renal Insufficiency; Urinary Tract Infections | 2007 |
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome | 2008 |